Zosano Pharma (ZSAN) PT Raised to $19 at BTIG as Company Steps-Up Manufacturing Momentum
Tweet Send to a Friend
BTIG analyst Robert Hazlett raised the price target on Zosano Pharma (NASDAQ: ZSAN) to $19.00 while maintaining a Buy rating ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
